Get started
Author

Damon A. Hofman

Observed names: Damon A Hofman, Damon Hofman
ORCID: 0000-0003-4411-4563
Observed ORCID: 0000-0003-4411-4563
OpenAlex ID: A5085403178
Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma
2024 · Damon A. Hofman, Jorge Ruiz-Orera, et al. · Molecular Cell · 89
PDF
Microproteins in cancer: identification, biological functions, and clinical implications
2024 · Damon A. Hofman, John R. Prensner, et al. · Trends in Genetics · 49
PDF
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch
2022 · Annelisa M Cornel, Ester Dunnebach, et al. · Journal for ImmunoTherapy of Cancer · 45
PDF
Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine
2022 · Mireia Palomar-Siles, Angelos Heldin, et al. · Cell Death and Disease · 32
PDF
Mutation Signatures of Pediatric Acute Myeloid Leukemia and Normal Blood Progenitors Associated with Differential Patient Outcomes
2021 · Arianne M. Brandsma, Eline J.M. Bertrums, et al. · Blood Cancer Discovery · 31
PDF
The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2024 · Michael V. Martin, Salvador Aguilar-Rosas, et al. · Cancer Immunology Research · 16
PDF
Mdb-32. Translation of Non-canonical Open Reading Frames as a Cancer Cell Survival Mechanism in Childhood Medulloblastoma
2023 · Damon Hofman, Jorge Ruiz-Orera, et al. · Neuro-Oncology · 1
PDF
Figure S13 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S14 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S16 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S11 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S12 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S9 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S4 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S6 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S2 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S5 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S1 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S3 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S15 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S7 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S10 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Figure S8 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Translational Changes upon Aging and Dietary Restriction in Progeroid DNA-Repair-Deficient Mice
2026 · Wilbert P. Vermeij, Ivar van Galen, et al.
PDF
Figure S10 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2024 · Michael V. Martin, Salvador Aguilar-Rosas, et al.
Works count: 64
Citation count: 263
H-index: 6
I10-index: 6
Year
Topic
Type